Home › Trial NCT06879704
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
- Trial IDNCT06879704
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorCentre Henri Becquerel
- Enrollment115
- Start date2025-05-28
- ConditionsTriple Negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.